BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32088583)

  • 1. The global burden of epilepsy report: Implications for low- and middle-income countries.
    Singh G; Sander JW
    Epilepsy Behav; 2020 Apr; 105():106949. PubMed ID: 32088583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Epilepsy Collaborators
    Lancet Neurol; 2019 Apr; 18(4):357-375. PubMed ID: 30773428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries.
    Singh G; Angwafor SA; Njamnshi AK; Fraimow H; Sander JW
    Nat Rev Neurol; 2020 Jun; 16(6):333-345. PubMed ID: 32427939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy surgery in low- and middle-income countries: A scoping review.
    Watila MM; Xiao F; Keezer MR; Miserocchi A; Winkler AS; McEvoy AW; Sander JW
    Epilepsy Behav; 2019 Mar; 92():311-326. PubMed ID: 30738248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of epilepsy--an unknown quantity.
    Beghi E; Hesdorffer D
    Epilepsia; 2014 Jul; 55(7):963-7. PubMed ID: 24966095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy in poor regions of the world.
    Newton CR; Garcia HH
    Lancet; 2012 Sep; 380(9848):1193-201. PubMed ID: 23021288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the management of epilepsy in resource-poor countries.
    Radhakrishnan K
    Nat Rev Neurol; 2009 Jun; 5(6):323-30. PubMed ID: 19455183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The global cost of epilepsy: A systematic review and extrapolation.
    Begley C; Wagner RG; Abraham A; Beghi E; Newton C; Kwon CS; Labiner D; Winkler AS
    Epilepsia; 2022 Apr; 63(4):892-903. PubMed ID: 35195894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality risks in children aged 5-14 years in low-income and middle-income countries: a systematic empirical analysis.
    Hill K; Zimmerman L; Jamison DT
    Lancet Glob Health; 2015 Oct; 3(10):e609-16. PubMed ID: 26254555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden and costs of chronic diseases in low-income and middle-income countries.
    Abegunde DO; Mathers CD; Adam T; Ortegon M; Strong K
    Lancet; 2007 Dec; 370(9603):1929-38. PubMed ID: 18063029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in epilepsy-31 inventory (QOLIE-31) scores: A global comparison.
    Saadi A; Patenaude B; Mateen FJ
    Epilepsy Behav; 2016 Dec; 65():13-17. PubMed ID: 27838562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urbanization and kidney function decline in low and middle income countries.
    Jagannathan R; Patzer RE
    BMC Nephrol; 2017 Aug; 18(1):276. PubMed ID: 28851306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of disease among the global poor.
    Gwatkin DR; Guillot M; Heuveline P
    Lancet; 1999 Aug; 354(9178):586-9. PubMed ID: 10470717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population ageing and mortality during 1990-2017: A global decomposition analysis.
    Cheng X; Yang Y; Schwebel DC; Liu Z; Li L; Cheng P; Ning P; Hu G
    PLoS Med; 2020 Jun; 17(6):e1003138. PubMed ID: 32511229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment gaps and challenges in epilepsy care in the Philippines.
    Moalong KMC; Espiritu AI; Fernandez MLL; Jamora RDG
    Epilepsy Behav; 2021 Feb; 115():107491. PubMed ID: 33323340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global burden of epilepsy.
    Leonardi M; Ustun TB
    Epilepsia; 2002; 43 Suppl 6():21-5. PubMed ID: 12190974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis.
    Kirk MD; Pires SM; Black RE; Caipo M; Crump JA; Devleesschauwer B; Döpfer D; Fazil A; Fischer-Walker CL; Hald T; Hall AJ; Keddy KH; Lake RJ; Lanata CF; Torgerson PR; Havelaar AH; Angulo FJ
    PLoS Med; 2015 Dec; 12(12):e1001921. PubMed ID: 26633831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The escalating global burden of serious health-related suffering: projections to 2060 by world regions, age groups, and health conditions.
    Sleeman KE; de Brito M; Etkind S; Nkhoma K; Guo P; Higginson IJ; Gomes B; Harding R
    Lancet Glob Health; 2019 Jul; 7(7):e883-e892. PubMed ID: 31129125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Economic Consequences Of Mortality Amenable To High-Quality Health Care In Low- And Middle-Income Countries.
    Alkire BC; Peters AW; Shrime MG; Meara JG
    Health Aff (Millwood); 2018 Jun; 37(6):988-996. PubMed ID: 29863936
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.